Long-term oral anticoagulation is a cornerstone of stroke prevention in patients with atrial
fibrillation (AF). Patient education should be provided regarding the need for anticoagulant …

Cardioembolic stroke from atrial fibrillation causes substantial death and disability in the
United States. Treatment with oral anticoagulants provides safe and effective stroke …

Atrial fibrillation is an acute or chronic arrhythmia that occurs postoperatively or during
intense emotional stress, exercise, or acute alcohol intoxication. More than 10% of …

Atrial fibrillation (AF) is becoming increasingly common in an ageing population. Much of the
morbidity and mortality in AF is due to stroke and thromboembolism. Awareness of stroke …

Get a quick, expert overview of stroke risks among patients with treated and untreated atrial
fibrillation, in addition to best practices for management and treatment of patients with atrial …

Atrial fibrillation is one of the most common causes of stroke in Canada. Although
antithrombotic guidelines clearly define optimal stroke prevention therapies in atrial …

Atrial fibrillation is a common condition that is associated with a high risk of stroke. In the
present article, which is based on a roundtable discussion held on February 8, 2012, the …

Patients with nonvalvular atrial fibrillation have an increased risk of cerebral
thromboembolism. Oral anticoagulation therapy, however, provides primary and secondary …

Background: Warfarin therapy substantially reduces stroke in atrial fibrillation (AF), yet
medical literature reports it is only prescribed in 15-60% of eligible patients. No current …

Ischemic stroke, a major complication of atrial fibrillation (AF), is believed to result from atrial
thrombus formation caused by ineffective atrial contraction. Oral anticoagulant therapy …